Format

Send to

Choose Destination
Radiother Oncol. 2010 Jun;95(3):371-80. doi: 10.1016/j.radonc.2010.04.022. Epub 2010 May 20.

The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.

Author information

1
Department of Experimental Clinical Oncology, Aarhus University Hospital, DK-8000 Aarhus C, Denmark. pernille@oncology.dk

Abstract

The profound influence of Human papillomavirus (HPV) on the epidemiological pattern and clinical course of head and neck cancer (HNSCC) has led to a change in the traditional understanding of this disease entity. Separate therapeutic strategies based on tumour HPV status are under consideration and in this light provision of knowledge concerning the influence of tumour HPV on the radiation response in HNSCC appears highly relevant. This review provides a summary of the current understanding of the role of HPV in head and neck cancer with specific focus on the viral impact on radiotherapy outcome of HNSCC.

PMID:
20493569
DOI:
10.1016/j.radonc.2010.04.022
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center